Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis
Ilaria Maccora, Preston Land, Virginia Miraldi Utz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 689-692
Open Access | Times Cited: 10

Showing 10 citing articles:

Risk factors for growth retardation in children with juvenile idiopathic arthritis: a case-control study
Ying Zhang, Liping Song, Weihu Ma, et al.
BMC Musculoskeletal Disorders (2025) Vol. 26, Iss. 1
Open Access
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries
Antonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Management of JIA associated uveitis
Ilaria Maccora, Gabriele Simonini, Catherine Guly, et al.
Best Practice & Research Clinical Rheumatology (2024), pp. 101979-101979
Closed Access | Times Cited: 2
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients
Ai Tien Nguyen, Isabelle Koné‐Paut, Perrine Dusser
Pediatric Drugs (2023) Vol. 26, Iss. 1, pp. 31-47
Closed Access | Times Cited: 5
2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4H-Chromen-4-One Flavones Based Virtual Screening for Potential JAK Inhibitors in Inflammatory Disorders
Sumit Deore, Pravin Tajane, Avinash Bhosale, et al.
International Research Journal of Multidisciplinary Scope (2024) Vol. 05, Iss. 01, pp. 557-567
Open Access | Times Cited: 1
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?
Ivan Foeldvari, Harry Petrushkin
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 267-276
Closed Access | Times Cited: 2
Janus Kinase Inhibitors: A Future All-Rounder in Axial Spondyloarthritis?
Jinxian Huang, James Cheng‐Chung Wei
Immunotherapy (2023) Vol. 15, Iss. 15, pp. 1195-1198
Closed Access | Times Cited: 1
A clearer vision: insights into juvenile idiopathic arthritis–associated uveitis
Ihda M. Bani Khalaf, Hritvik Jain, Nilofar Murtaza Vora, et al.
Baylor University Medical Center Proceedings (2024) Vol. 37, Iss. 2, pp. 303-311
Open Access
Janus Kinase Inhibitors as a Third-Line Therapy for Refractory Endogenous Noninfectious Uveitis
Justus G. Garweg, Kim A. Straessle
Ocular Immunology and Inflammation (2024), pp. 1-8
Closed Access
Screen high-risk paediatric patients for non-infectious uveitis and consider its treatment options
Simon Fung
Drugs & Therapy Perspectives (2024) Vol. 40, Iss. 8, pp. 304-309
Closed Access
Page 1

Scroll to top